Epidemiological report and diagnostic approach used in the neuromuscular population of Liege, Belgium
Rattachement africain : be, gb. Niveau de preuve : code pays fourni par la source.
Le résumé fourni par la source
BACKGROUND: Patients with neuromuscular diseases (NMD) have undergone considerable technological progress in terms of diagnosis and treatment over the past few years. Specifically, next-generation sequencing (NGS) has significantly expanded genetic diagnosis. Despite this, some patients remain undiagnosed and therefore without access to specific treatments. Analyses of epidemiology and diagnostic approaches in reference centers are required to determine effective strategies to improve diagnostic rates. METHODS: We studied the proportion of each NMD and associated investigations in the patient population of the Neuromuscular Reference Center (NMRC) of Liege, Belgium, in 2023. The investigation tools used included laboratory testing, muscle biopsy, muscle imaging, single-gene sequencing, targeted NGS panels, and whole-exome sequencing (WES). RESULTS: Of the 1084 patients who were regularly followed up, more than one-third had neuropathies (36.6%) that were divided equally between genetic and acquired causes. The second most common disorder was muscular dystrophies, which represented more than a quarter (27.5%). Third, 11.2% of the patients had motor neuron diseases. The other NMD (i.e., myopathies, ataxias, spastic paraplegias, and channelopathies) ranged from 2.1% to 6. %. A total of 13.7% of the patients had unconfirmed diagnoses, 31.5% had confirmed acquired disorders, and 54.9% had genetically confirmed disorders. Among the genetic diagnoses, 32.7% were obtained by NGS. The remaining 67.3% were determined using other genetic testing methods [i.e., array comparative genomic hybridization (aCGH), multiplex ligation-dependent probe amplification (MLPA), polymerase chain reaction (PCR), southern blotting (SB)]. CONCLUSION: More than two-thirds of patients received a definitive diagnosis without the use of next-generation sequencing. Although innovative technologies such as whole genome sequencing and long-read sequencing are expected to eventually replace NGS panels and traditional methods (e.g., MLPA, PCR, aCGH), their current cost and the complexity of variant interpretation limit their widespread use in routine clinical practice. As a result, these older techniques remain relevant and valuable in current diagnostic workflow.
Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.
Le contrôle bibliographique ouvert
DOI retrouvé dans Crossref DOI retrouvé ; titre concordant.
- Titre Crossref
- Epidemiological report and diagnostic approach used in the neuromuscular population of Liege, Belgium
- Date Crossref
- 29/08/2025
- Éditeur
- Springer Science and Business Media LLC
- Type
- journal-article
Ce recoupement confirme des métadonnées liées au DOI. Il ne confirme ni la méthode ni les conclusions de l’étude, et il ne compte pas comme une seconde source scientifique indépendante.
Où se fait cette recherche
-
University of Liège Rare Movement Disorders Research Group - GIGA Human Imaging pays non établi dans la noticeUniversité ou école supérieure
-
Centre Hospitalier Universitaire de Liège pays non établi dans la noticeÉtablissement de santé
-
Centre hospitalier régional de la Citadelle pays non établi dans la noticeÉtablissement de santé
-
University of Oxford MDUK Oxford Neuromuscular Centre & NIHR Oxford Biomedical Research Centre pays non établi dans la noticeUniversité ou école supérieure
-
Oxford BioMedica (United Kingdom) pays non établi dans la noticeEntreprise
-
Clinical Genetics Department pays non établi dans la noticeÉtablissement de santé
-
University Hospital Liège Department of Pediatrics pays non établi dans la noticeUniversité ou école supérieure
-
University Department of Neurology pays non établi dans la noticeUniversité ou école supérieure
-
University Department of Pediatrics pays non établi dans la noticeUniversité ou école supérieure
Rare Movement Disorders Research Group - GIGA Human Imaging — University of Liège, Centre Hospitalier Universitaire de Liège et Centre hospitalier régional de la Citadelle, avec 6 autres affiliations.
Une affiliation ne permet pas de déduire la nationalité d’un auteur.